LONDON-Researchers want drug resistance tested for patients recently infected with the HIV virus. They say the information could help with the clinical management of patients.
Deenan Pillay, MD, from the University of Birmingham medical School, worked with a team of researchers to test blood samples of 69 HIV-infected patients. All of the patients had a negative HIV antibody test after 18 months. They found nucleotide sequencing of the reverse transcriptase and protease genes of the isolated virus.
A mutation caused by drug resistance was found in 14% of the patients. They estimated that the transmission of drug-resistant HIV was 27%.
The increase in drug-resistant HIV has been tied to unsafe sex practices by Pillay. However, he said that the findings should not create a doomsday scenario because for the majority of people infected, there are still drugs that will work effectively.
Information from www.hivandhepatitis.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.